10 structures "https:" "https:" "https:" "https:" "https:" "IMT Atlantique" Fellowship research jobs at City of Hope
-
Medicine, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug
-
. Gu’s lab and research, please visit: https://gu-lab.net and https://www.cityofhope.org/Zhaohui-Gu As a successful candidate, you will: Design and execute experiments to understand the molecular
-
-life environmental exposures and the prenatal origins of childhood leukemia, for example in our ReCord Study (https://record.umn.edu ). Applicants are required to submit a CV accompanied by a cover
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages
-
Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
models to study metabolic diseases is preferred. For a complete list of Publications please visit here: https://www.ncbi.nlm.nih.gov/myncbi/1J54E41I5YVku/bibliography/public/ Your qualifications should
-
: https://www.nathlab.org As a successful candidate, you will: Collaborate closely with experimental scientists, mathematicians, and medical oncologists/surgeons to plan, design, and execute computational
-
, Cancer Biology, Chromatin Regulation, Cancer Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics
-
supportive, nonhierarchical and inclusive lab structure, promoting open communication, scientific curiosity and creativity, by building strong collaborations. We also provide an excellent opportunity to thrive
-
antibody-based approach to intervene the malignancies 3) Identification of novel therapeutic target using high-throughput CRISPR genetic screen (e.g., metabolic pathway, mitochondria structure) in immune